Robotic Neurorehabilitation Market Size (2024 - 2029)

Robotic Neurorehabilitation Market Analysis

The Robotic Neurorehabilitation Market size is estimated at USD 0.84 billion in 2024, and is expected to reach USD 2.08 billion by 2029, growing at a CAGR of 19.76% during the forecast period (2024-2029).

Robot-mediated neurorehabilitation is an emerging field incorporating advances in robotic technology with neuroscience rehabilitation to define novel methods for treating neurological disorders. The demand for these products and services is attributed to the increasing prevalence of neurological disorders such as Parkinson's disease, cerebral palsy, and multiple sclerosis, coupled with increasing cases of stroke and brain and spinal cord injuries. For instance, according to a study published by the Lancet Neurology Journal in March 2024, over 3.4 billion people across the world are affected by a diverse group of neurological conditions, of which the highest contributors are stroke, neonatal encephalopathy or brain injury, migraine, Alzheimer's disease, and other dementias. The increasing patient population with neurological diseases causing motor or cognitive impairments, especially in the rapidly aging population, is expected to surge the demand for neurorehabilitation therapy over the forecast period.

Furthermore, several studies suggested that rehabilitation robots, which include therapeutic and assistive robots, support the neurorehabilitation of persons with neurological injuries and help bridge the care gap. These robotic neurorehabilitation devices are based on motor learning, resulting from intensive, repetitive, and task-oriented motor activities that require a patient's effort and attention. For instance, as per a study published by the Medical Review in February 2024, robot-assisted therapy combined with task-specific training has shown superior results in upper extremity motor function and improvements in quality of life among the Chinese population within post-stroke rehabilitation. Therefore, the frequent lack of complete recovery makes it desirable to develop novel neurorehabilitative treatments suited to the patients and better targeting the specific disability. Thus, robotic care in rehabilitation may play an essential role in the coming years.

Moreover, the increasing number of rehabilitation facilities and growing investment to accelerate research and development activities to incorporate robotic technology in rehabilitation therapy are surging the demand for these products and services across the globe. For instance, in September 2023, Trilife Hospital invested USD 180.4 million (INR 1,500 crore) to establish five new hospitals with the introduction of robotic services for advanced neuro-rehabilitation in India. Such initiatives are expected to increase accessibility and improve clinical outcomes in patients with neurologic disorders and are anticipated to surge the demand for robotic neurorehabilitation solutions, leading to market growth.

However, there are numerous barriers to the adoption of robot technology in rehabilitation. Such high levels of investments, its relatively costly maintenance and routine operation, and the lack of acceptance from healthcare professionals may restrain the market's growth.

Robotic Neurorehabilitation Industry Segmentation

Robot-assisted rehabilitation is a type of technology that helps the functional recovery of patients with stroke, traumatic brain injury, cerebral palsy, spinal cord injuries, Parkinson’s disease, and multiple sclerosis. Robotic neurorehabilitation devices are typically based on motor learning, which requires a patient’s effort and attention to perform intensive, repetitive, and task-oriented motor activities.

The robotic neurorehabilitation market is segmented into product type, end user, and geography. The market is segmented by product type into devices, consumables, accessories, and software and services. By devices, the market is segmented into upper extremity and lower extremity. By end user, the market is segmented into hospitals/clinics, cognitive care centers, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. The report also offers the market size and forecasts for 13 countries across the region. For each segment, the market sizing and forecasts have been done on the basis of value (USD)